-
2023-504425-39-00
3
Respiratory Syncytial Virus (RSV) Infection
-
2023-507319-36-00
5
Inguinal or femoral hernia
-
2024-515448-22-00
4
Parkinson
-
2024-519298-21-00
5
Cancer-Associated Thrombosis (CAT).
-
2025-520826-39-00
5
ACUTE RESPIRATORY DISTRESS SYNDROME
-
2025-521113-13-00
10
Early Parkinson’s Disease
-
2025-524646-94-00
11
Obstetrics – Preeclampsia
-
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
-
2022-503070-36-00
5
2025-12-23
Group B streptococcus (GBS) disease
-
2024-518521-14-00
6
2025-10-17
Critical condition
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2024-514833-39-00
3
2024-12-16
Stress or mixed urinary incontinence in women over 50 years of age not
-
2024-511959-18-01
5
2024-07-01
Acute Pulmonary Embolism
-
2023-505024-62-01
4
2024-05-16
Oligometastatic patients with castration-resistant
prostate cancer
-
2023-507293-40-00
6
2024-04-11
VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA
-
2023-505687-11-00
5
2024-02-06
Acute pain
-
2024-519319-32-00
7
2025-08-27
Urinary Tract Infections
-
2023-505601-16-00
5
2025-04-22
Chronic Migraine
-
2023-510465-10-00
4
2025-03-10
Meningococcal immunization
-
2023-505739-12-01
5
2024-09-30
Chronic Inducible Urticaria (CINDU)
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2023-503403-28-00
4
2022-11-25
treatment naïve patients with HR+/HER2-negative high-risk early breast
-
2024-517008-12-00
5
2022-10-14
Newly-diagnosed multiple myeloma (NDMM)
-
2024-514630-21-00
4
2022-08-11
HER2 positive (HER2+), Hormone Receptor positive (HR+) Early-stage Bre